<DOC>
	<DOCNO>NCT02552641</DOCNO>
	<brief_summary>The purpose study ass whether various form triple regimen administration treatment Helicobacter pylorus ( meal ( fast ) , meal , independent mealtime ) influence rate eradication bacterium .</brief_summary>
	<brief_title>Food Effect Eradication Rate H. Pylori With Triple Therapy With Esomeprazole</brief_title>
	<detailed_description>Phase IV , open , randomize , prospective study . - Length experience : 180 day . - 06 visit . - Evaluation efficacy difference regimens administration .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Participants sex ; Age great equal 18 less equal 50 year ; Participant diagnose type dyspepsia epigastric pain carrier Helicobacter pylorus infection , accord classification ROME III ; Ability understand consent participate clinical study , manifest reading , understand signing Informed Consent ( IC ) . Any find clinical observation ( clinical evaluation / physical ) interpret investigator medical risk participate clinical trial ; Any laboratory examination find investigator doctor considers risk research participant participation clinical trial ; Known hypersensitivity drug component use study ; Women pregnancy breastfeed period ; Women reproductive age agree use acceptable method contraception ( oral contraceptive , injectable contraceptive , IUD , hormonal implant , barrier method , abstinence , hormonal patch tubal ligation ) ; except surgically sterile ( bilateral oophorectomy hysterectomy ) ; Participating research participate clinical trial protocol last twelve ( 12 ) month ( CNS Resolution 251 August 7 , 1997 , Part III , subitem J ) , unless investigator considers may direct benefit ; Party kinship second degree bond employee employee Sponsor Research Center ; Patients predominant symptom reflux irritable bowel syndrome , warn symptom , peptic ulcer history previous surgery upper segment gastrointestinal tract ; Patients prior treatment history eradication Helicobacter pylorus ; Patients kidney , liver heart failure ; Patients past current history alcohol abuse ; Patients history use antibiotic bismuth 4 week prior study entry , PPIs H2 blocker , NSAIDs aspirin last two week ; Patients whose endoscopy show change except hyperemic gastritis , erosive gastritis den consider maximum 5 erosion location hiatal hernia ; Patients whose ultrasonography show hepatobiliopancreatic change except steatosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>